Clinical Trial Update: Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study [Phase 1, Phase 2]

View source ↗

Summary

A randomized, controlled Phase 1/2 trial evaluating the safety, immune response, and early efficacy of a Candida vaccine in women with recurrent vulvovaginal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• LimmaTech Candida Vaccine (Candida vaccine)

Snippet

Sponsor: LimmaTech Biologics AG | Conditions: Recurrent Vulvovaginal Candidiasis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING